Emily Hare serves as the Senior Vice President of Clinical Operations at Baylor Genetics, bringing over 20 years of experience in genomics, product development, and operations. She is responsible for overseeing all aspects of clinical operations, driving innovation, and ensuring excellence in delivering high-quality results.

Prior to joining Baylor Genetics, Emily held leadership roles at Invitae, where she scaled operations to support rapid growth, led cross-functional teams through groundbreaking product launches, and implemented strategies that improved efficiency and outcomes. Her career is defined by her passion for using cutting-edge genomic technologies to improve healthcare access and patient care.

Emily earned her PhD in Molecular and Cell Biology with a Designated Emphasis in Computational Biology from the University of California, Berkeley. She also completed a postdoctoral fellowship at Stanford University and holds a Bachelor of Arts in Biology from the University of San Diego, graduating summa cum laude.